Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 22, 2022

Characteristics of New Users of Recent Antidiabetic Drugs in Canada and the UK

BMC Endocrine Disorders


Additional Info

BMC Endocrine Disorders
Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom
BMC Endocr Disord 2022 Sep 29;22(1)241, VC Brunetti, A St-Jean, S Dell'Aniello, A Fisher, OHY Yu, SC Bugden, JM Daigle, N Hu, S Alessi-Severini, BR Shah, PE Ronksley, LM Lix, P Ernst, KB Filion

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading